Hospira, Inc., is recalling one lot of its injectable drug Lidocaine because of a confirmed report of discolored solution with visible particles floating in it as well as particulate embedded in the molded glass container. Hospira has identified the particulate as iron oxide, and said it is due to a supplier’s glass defect. Hospira is working with its supplier on implementing corrective and preventative actions. To date, no adverse events have been reported related to this recall, however if patients are injected with the particles – depending on the particle size and number – it could block administration of the ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.